Our previous work demonstrated that ARID1A was mutated in 13% of hepatitis B virus (HBV) infection-associated hepatocellular carcinoma (HCC) specimens, and ARID1A mutations were considered as a crucial event in liver cancer metastasis [5]. This evidence concerns the gene ARID1A and hepatocellular carcinoma.